• 7ACC2 and Immunometabolic Targeting: Redefining MCT1 Inhibit

  2026-05-30

  Explore how 7ACC2, a potent monocarboxylate transporter 1 inhibitor, uniquely intersects cancer metabolism and immunometabolic reprogramming. This article offers a deeper analysis of lactate transport inhibition's impact on tumor immunology and assay design.

• Cefodizime: Antibacterial Activity and Research Utility Revi

  2026-05-29

  This review analyzes the pharmacological innovation, spectrum of activity, and clinical efficacy of cefodizime, a third-generation cephalosporin antibiotic. It discusses the compound’s distinctive features, including β-lactamase stability and immunomodulatory potential, and highlights its relevance for infectious disease research and experimental modeling.

• WY-14643 (Pirinixic Acid): Strategic PPARα Modulation in Tra

  2026-05-29

  This thought-leadership article advances the conversation on WY-14643 (Pirinixic Acid) by blending mechanistic insights with practical strategic guidance for translational researchers. Drawing on recent multiomics evidence and bridging metabolic disorder, inflammation, and tumor microenvironment research, this piece offers a roadmap for maximizing the translational impact of PPARα agonism with WY-14643, while situating it within the competitive and scientific landscape.

• Intra- and Extracellular Dicloxacillin Activity Against MSSA

  2026-05-28

  This study systematically evaluates the intra- and extracellular activities of dicloxacillin against Staphylococcus aureus, revealing that its efficacy is comparable in both environments and that the time above MIC best predicts therapeutic success. These findings refine experimental design and pharmacodynamic targeting for Gram-positive bacterial infection research.

• Cinoxacin: Quinolone Antibiotic Workflows for UTI Research

  2026-05-28

  Cinoxacin, a quinolone antibiotic from APExBIO, enables high-precision urinary tract infection and resistance studies with reproducible, data-driven workflows. Its potent activity against Gram-negative bacteria, tightly defined MICs, and well-characterized mechanism make it a cornerstone tool for both foundational and translational research.

• Cl-Amidine trifluoroacetate salt: Redefining PAD4 Inhibition

  2026-05-27

  Explore how Cl-Amidine trifluoroacetate salt enables precise, translational control of PAD4 in immunoepigenetic research. This article delivers an advanced, evidence-based perspective on mechanistic applications and assay optimization, extending beyond standard protocols.

• Ampicillin Sodium: Applied Workflows and Troubleshooting in

  2026-05-27

  Ampicillin sodium stands out as a benchmark β-lactam antibiotic for robust antibacterial activity assays and infection models. This article details evidence-backed protocols, troubleshooting insights, and comparative strategies, drawing on recent research to empower reproducibility and precision in laboratory workflows.

• Tetraethylammonium Chloride: Precision K+ Channel Blockade i

  2026-05-26

  Tetraethylammonium chloride (TEAC) stands out as a benchmark K+ channel blocker for dissecting ion conduction and vascular signaling, enabling robust pharmacological and physiological assays. This article translates cutting-edge findings and practical troubleshooting strategies into actionable workflows for researchers leveraging TEAC from APExBIO.

• Mianserin HCl: 5-HT2 Antagonist Workflows & Troubleshooting

  2026-05-26

  Mianserin HCl stands apart as a precise 5-HT2 receptor antagonist for antidepressant, neuroscience, and antipathogenic research. This guide delivers actionable workflow enhancements, protocol parameters, and troubleshooting insights—leveraging new evidence on cyclodextrin complexation to optimize your experimental outcomes.

• Difloxacin HCl (A8411): Reliable Antimicrobial for Cell Assa

  2026-05-25

  This evidence-based article addresses core challenges in laboratory assays involving cell viability, proliferation, and multidrug resistance, highlighting the role of Difloxacin HCl (SKU A8411) from APExBIO. By unpacking real-world scenarios, we demonstrate how this quinolone antimicrobial antibiotic ensures reproducibility, sensitivity, and workflow confidence for biomedical researchers.

• Cefazedone (Refosporen): Applied Workflows and Troubleshooti

  2026-05-25

  Cefazedone (Refosporen) delivers β-lactamase-resistant, broad-spectrum antibacterial activity ideal for robust in vitro and preclinical workflows. This article translates cutting-edge research into actionable protocols, comparative advantages, and troubleshooting strategies to maximize reproducibility and sensitivity in Gram-positive and Gram-negative bacterial assays.

• Plk1 Regulation of p31comet in Mitotic Checkpoint Complex Di

  2026-05-24

  This study elucidates how Polo-like kinase 1 (Plk1) regulates the function of p31comet, a key protein in the disassembly of mitotic checkpoint complexes (MCC). The findings clarify checkpoint inactivation mechanisms, with implications for understanding chromosome segregation fidelity and potential intersections with research on cell cycle control and drug resistance.

• Targeting Glutamine Metabolism in HSCs to Combat Liver Fibro

  2026-05-23

  The referenced study uncovers that hepatic stellate cell (HSC) activation and liver fibrosis are tightly linked to glutamine metabolism, particularly via GDH activity and SIRT4 regulation. By demonstrating that modulation of these pathways attenuates fibrosis, the research establishes metabolic control as a promising therapeutic direction for chronic liver disease.

• KPT-330 (Selinexor): Optimizing CRM1 Inhibition for Cancer R

  2026-05-22

  KPT-330 (Selinexor) enables precise inhibition of nuclear export, driving apoptosis and cell cycle arrest in diverse cancer models. This article delivers actionable protocols, troubleshooting insights, and new combinatorial approaches—anchored by the latest evidence linking XPO1 inhibition to enhanced chemotherapy sensitivity.

• Olive Oil Polyphenols: Mechanisms in Cardiovascular Protecti

  2026-05-22

  This article reviews Boumezough et al. (2025), who dissect the mechanistic contributions of olive oil polyphenols—specifically hydroxytyrosol and tyrosol—to cardiovascular health. By directly comparing standard and high-phenolic extra virgin olive oil (EVOO) extracts, the study clarifies dose-dependent antioxidant, anti-inflammatory, and anti-atherogenic effects, providing a foundation for targeted research on phenolic bioactivity.

16306 records 1/1088 page Next 12345 下5页 Last page